A/DT
mechanism/NN
for/IN
the/DT
antiinflammatory/JJ
effects/NNS
of/IN
corticosteroids/NNS
:/:
the/DT
glucocorticoid/NN
receptor/NN
regulates/VBZ
leukocyte/NN
adhesion/NN
to/TO
endothelial/JJ
cells/NNS
and/CC
expression/NN
of/IN
endothelial-leukocyte/JJ
adhesion/NN
molecule/NN
1/CD
and/CC
intercellular/JJ
adhesion/NN
molecule/NN
1/CD
./.

Corticosteroids/NNS
are/VBP
the/DT
preeminent/JJ
antiinflammatory/JJ
agents/NNS
although/IN
the/DT
molecular/JJ
mechanisms/NNS
that/WDT
impart/VBP
their/PRP$
efficacy/NN
have/VBP
not/RB
been/VBN
defined/VBN
./.
=====
The/DT
endothelium/NN
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
inflammation/NN
by/IN
directing/VBG
circulating/VBG
leukocytes/NNS
into/IN
extravascular/JJ
tissues/NNS
by/IN
expressing/VBG
adhesive/JJ
molecules/NNS
for/IN
leukocytes/NNS
[/(
e.g./FW
,/,
endothelial-leukocyte/JJ
adhesion/NN
molecule/NN
1/CD
(/(
ELAM-1/NN
)/)
and/CC
intercellular/JJ
adhesion/NN
molecule/NN
1/CD
(/(
ICAM-1/NN
)/)
]/)
./.
=====
We/PRP
therefore/RB
determined/VBD
whether/IN
corticosteroids/NNS
suppress/VBP
inflammation/NN
by/IN
inhibiting/VBG
endothelial/JJ
expression/NN
of/IN
adhesion/NN
molecules/NNS
for/IN
neutrophils/NNS
(/(
polymorphonuclear/JJ
leukocytes/NNS
)/)
./.
=====
Preincubation/NN
of/IN
endothelial/JJ
cells/NNS
with/IN
endotoxin/NN
[/(
lipopolysaccharide/NN
(/(
LPS/NN
)/)
,/,
1/CD
microgram/ml/NN
]/)
led/VBD
to/TO
a/DT
4-fold/JJ
increase/NN
in/IN
subsequent/JJ
adherence/NN
of/IN
polymorphonuclear/JJ
leukocytes/NNS
(/(
P/NN
</JJR
0.0001/CD
,/,
n/NN
=/JJ
10/CD
)/)
to/TO
endothelial/JJ
cells/NNS
,/,
an/DT
increase/NN
that/WDT
was/VBD
markedly/RB
attenuated/VBN
when/WRB
endothelial/JJ
cells/NNS
were/VBD
treated/VBN
with/IN
dexamethasone/NN
(/(
IC50/NN
</JJR
1/CD
nM/NN
,/,
P/NN
</JJR
0.0001/CD
,/,
n/NN
=/JJ
6/CD
or/CC
7/CD
)/)
during/IN
preincubation/NN
with/IN
LPS/NN
./.
=====
Moreover/RB
,/,
the/DT
steroid/NN
receptor/NN
agonist/NN
cortisol/NN
(/(
10/CD
microM/NN
)/)
,/,
but/CC
not/RB
its/PRP$
inactive/JJ
metabolite/NN
tetrahydrocortisol/NN
(/(
10/CD
microM/NN
)/)
,/,
diminished/VBD
LPS-induced/JJ
endothelial/JJ
cell/NN
adhesiveness/NN
./.
=====
Further/JJ
evidence/NN
that/IN
the/DT
action/NN
of/IN
dexamethasone/NN
was/VBD
mediated/VBN
through/IN
ligation/NN
of/IN
corticosteroid/NN
receptors/NNS
[/(
human/JJ
glucocorticoid/NN
receptors/NNS
(/(
hGRs/NNS
)/)
]/)
was/VBD
provided/VBN
by/IN
experiments/NNS
utilizing/VBG
the/DT
steroid/NN
antagonist/NN
RU-486/NN
./.
=====
RU-486/NN
(/(
10/CD
microM/NN
)/)
,/,
which/WDT
prevents/VBZ
translocation/NN
of/IN
ligated/VBN
hGR/NN
to/TO
the/DT
nucleus/NN
by/IN
inhibiting/VBG
dissociation/NN
of/IN
hGR/NN
from/IN
heat/NN
shock/NN
protein/NN
90/CD
,/,
completely/RB
aborted/VBD
the/DT
effect/NN
of/IN
dexamethasone/NN
on/IN
adhesiveness/NN
of/IN
endothelial/JJ
cells/NNS
(/(
P/NN
</JJR
0.0005/CD
,/,
n/NN
=/JJ
3/CD
)/)
./.
=====
Treatment/NN
of/IN
endothelial/JJ
cells/NNS
with/IN
LPS/NN
(/(
1/CD
microgram/ml/NN
)/)
stimulated/VBD
transcription/NN
of/IN
ELAM-1/NN
,/,
as/IN
shown/VBN
by/IN
Northern/NN
blot/NN
analysis/NN
,/,
and/CC
expression/NN
of/IN
membrane-associated/JJ
ELAM-1/NN
and/CC
ICAM-1/NN
,/,
as/IN
shown/VBN
by/IN
quantitative/JJ
immunofluorescence/NN
(/(
both/DT
P/NN
</JJR
0.001/CD
,/,
n/NN
=/JJ
9/CD
)/)
./.
=====
Dexamethasone/NN
markedly/RB
inhibited/VBD
LPS-stimulated/JJ
accumulation/NN
of/IN
mRNA/NN
for/IN
ELAM-1/NN
and/CC
expression/NN
of/IN
ELAM-1/NN
and/CC
ICAM-1/NN
(/(
IC50/NN
</JJR
10/CD
nM/NN
,/,
both/DT
P/NN
</JJR
0.001/CD
,/,
n/NN
=/JJ
4-9/CD
)/)
;/:
inhibition/NN
of/IN
expression/NN
by/IN
dexamethasone/NN
was/VBD
reversed/VBN
by/IN
RU-486/NN
(/(
both/DT
P/NN
</JJR
0.005/CD
,/,
n/NN
=/JJ
4-6/CD
)/)
./.
=====
As/IN
in/IN
the/DT
adhesion/NN
studies/NNS
,/,
cortisol/NN
but/CC
not/RB
tetrahydrocortisol/NN
inhibited/VBD
expression/NN
of/IN
ELAM-1/NN
and/CC
ICAM-1/NN
(/(
both/DT
P/NN
</JJR
0.005/CD
,/,
n/NN
=/JJ
3/CD
or/CC
4/CD
)/)
./.
=====
In/IN
contrast/NN
,/,
sodium/NN
salicylate/NN
(/(
1/CD
mM/NN
)/)
inhibited/VBD
neither/CC
adhesion/NN
nor/CC
expression/NN
of/IN
these/DT
adhesion/NN
molecules/NNS
./.
=====
These/DT
studies/NNS
suggest/VBP
that/IN
antagonism/NN
by/IN
dexamethasone/NN
of/IN
endotoxin-induced/JJ
inflammation/NN
is/VBZ
a/DT
specific/JJ
instance/NN
of/IN
the/DT
general/JJ
biological/JJ
principle/NN
that/IN
the/DT
glucocorticoid/NN
receptor/NN
is/VBZ
a/DT
hormone-dependent/JJ
regulator/NN
of/IN
transcription/NN
./.